Eugenii (Ilan) Rabiner FCPsych SA. is the Head or Imaging Applications and Chief Medical Officer at Imanova Ltd, an imaging centre specializing in translational molecular research designed to optimize early phase drug development. He is also a Reader in Molecular Neuroimaging at the Centre for Neuroimaging Scieces, Institute of Psychiatry, Psychology and Neuroscience of King’s College, London.
Dr. Rabiner is a psychiatrist with expertise in the application of PET imaging to problems of neuropsychopharmacology and drug development. Dr. Rabiner was the Head of Clinical Imaging Applications at the GSK Clinical Imaging Centre, and is an expert in the of imaging methodologies to accelerate the drug development pipeline.Dr. Rabiner’s research focuses on the development and application of molecular and functional imaging methods to problems of neuropsychophramacology.
Dr. Rabiner has co-authored over 120 peer-reviewed publication.